Tate & Lyle and McNeil Nutritionals Announce Global Sucralose Alliance

| Filed in:
Tate & Lyle PLC (‘Tate & Lyle’) and McNeil Nutritionals (‘McNeil’), a Johnson & Johnson company, announced today the realignment of their sucralose activities into a new global alliance designed to maximize the market penetration and accelerate the worldwide growth of sucralose. Existing sucralose sales and marketing arrangements have been restructured to play to the geographic and market strengths of each company.

Under the agreement, the companies will co-operate closely to further the development of the sucralose business. Tate & Lyle will act as exclusive broker for sucralose ingredient sales in certain key markets outside of North America. McNeil will exclusively market the Splenda® tabletop brand of sucralose to retailers worldwide.

The formation of this alliance represents a continuance of the 20-year partnership between the two companies. Sucralose, a non-caloric sweetener made from sugar, is manufactured by McNeil in the United States, and is currently approved in over 40 countries worldwide.

Larry Pillard, Chief Executive of Tate & Lyle said:
‘We are glad to be able to further our long-standing relationship with McNeil through this alliance. The new arrangements will enable us to leverage our global sales network and offer this exciting product to more of our customers alongside our existing range of value added carbohydrate-based food ingredients and sweeteners.’

About Tate & Lyle: 
Tate & Lyle is a global provider of solutions and ingredients for food, beverage and industrial markets.

Tate & Lyle operates through two global divisions, Food & Beverage Solutions and Primary Products, supported by the Innovation and Commercial Development and Global Operations teams. Food & Beverage Solutions is focused on growth by building leading positions globally in the categories of beverages, dairy, and soups, sauces and dressings. Primary Products is focused on delivering steady earnings and generating cash.

Food & Beverage Solutions consists of: Texturants, including speciality starches; Sweeteners, including low- and no-calorie sweeteners; and a Health and Wellness portfolio comprising mainly speciality fibres; and Stabilisers and Functional Systems, which are bespoke ingredient blends that ensure foods retain their structure.

Primary Products consists of high-volume sweeteners, industrial starches and fermentation products (primarily acidulants).  It also sells co-products from the corn milling process as animal nutrition.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2018, Tate & Lyle sales totalled £2.7 billion. For more information, please visit http://www.tateandlyle.com